Please note that eDoc will be permanently shut down in the first quarter of 2021!      Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Display Documents


Institute:
Collection:
Print in Citation style Print version     Display:
Sort by:
 Basket 
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
Authors: Sadr-Nabavi, A.; Ramser, J.; Volkmann, J.; Naehrig, J.; Wiesmann, F.; Betz, B.; Hellebrand, H.; Engert, S.; Seitz, S.; Kreutzfeld, R.; Sasaki, T.; Arnold, N.; Schmutzler, R.; Kiechle, M.; Niederacher, D.; Harbeck, N.; Dahl, E.; Meindl, A.
Date of Publication (YYYY-MM-DD): 2009-04-01
Title of Journal: International Journal of Cancer
Volume: 124
Issue / Number: 7
Start Page: 1727
End Page: 1735
Document Type: Article
ID: 423858.0
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.